April 22, 2024

Arla Foods Ingredients receives positive EFSA opinion

Arla Foods Ingredients has secured a positive opinion on its Novel Food application for Bovine Milk Osteopontin ingredient Lacprodan® OPN-10.

The European Food Safety Authority (EFSA) has published an opinion that Bovine Milk Osteopontin (OPN) is safe for use in infant formula (IF), follow-on formula and ready-to-eat dairy-based meals for children.

When this process is complete, Lacprodan® OPN-10 will become Arla Foods Ingredients’ first product for infant nutrition approved under the new Novel Food Regulation (EU) 2015/2283. Products containing Lacprodan® OPN-10 will be authorised for sale in Europe towards the end of 2022 or early 2023.

Osteopontin is a whey protein, which is a heavily phosphorylated, acidic glycoprotein with strong calcium-binding properties. Significant amounts of this protein have been identified in human milk, while smaller quantities are present in bovine milk. This means that – to date – infant formulas have had lower osteopontin content than human breast milk.

Anders Steen Jørgensen, Director Pediatric at Arla Foods Ingredients said: “We’re delighted by this decision, which is a significant step towards achieving Novel Food approval. It’s a strong signal of trustworthiness in this new ingredient for infant milk formula, and opens up new opportunities for formula manufacturers. This is the result of more than five years of hard work from our R&D department, Early Life Nutrition Science teams and regulatory teams. Lacprodan® OPN-10 is a fantastic addition to our infant nutrition portfolio and continues our record of being first to market with products in this sector.”

With Lacprodan® OPN-10, Arla Foods Ingredients can now help infant formula manufacturers to develop products containing osteopontin in its purest form to date. Arla Foods Ingredients holds several patents for the production and application of osteopontin.

About Novel Food

The European Commission defines Novel Food as food that had not been consumed to a significant degree by humans in the EU before 15 May 1997, when the first regulation on Novel Food came into force.

It can be applied to newly developed, innovative food, food produced using new technologies and production processes, as well as food which is or has been traditionally eaten outside of the EU.

Related articles

MycoTechnology to take its mushroom mycelia platform onto the global stage

MycoTechnology Inc., the world’s leading explorer of mushroom mycelia, has set its sights on achieving global scale and realizing its innovation pipeline after securing a funding injection of $85 million. The recently concluded Series E fundraise represents the Colorado-based company’s largest single round of financing since it was established in 2013, bringing total fundraising to-date

ADM identifies four factors that will drive the expansion of the Alternative Protein Ecosystem

ADM (NYSE: ADM), a global leader in human and animal nutrition, released its outlook on what’s driving the advancement of the protein ecosystem. The report details four factors driving the expansion of protein choices to feed the world’s growing population while keeping the planet’s best interest in mind.“Creating a sustainable and secure food system that